Denali Therapeutics, Inc. (DNLI)
24.46
-0.47
(-1.89%)
USD |
NASDAQ |
Aug 26, 11:43
Denali Therapeutics Market Cap : 3.908B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 3.983B |
| August 24, 2026 | 3.866B |
| August 21, 2026 | 3.981B |
| August 20, 2026 | 3.986B |
| August 19, 2026 | 4.104B |
| August 18, 2026 | 3.884B |
| August 17, 2026 | 3.890B |
| August 14, 2026 | 3.898B |
| August 13, 2026 | 3.965B |
| August 12, 2026 | 4.037B |
| August 11, 2026 | 3.944B |
| August 10, 2026 | 3.994B |
| August 07, 2026 | 3.967B |
| August 06, 2026 | 3.951B |
| August 05, 2026 | 3.901B |
| August 04, 2026 | 3.861B |
| August 03, 2026 | 3.673B |
| July 31, 2026 | 3.652B |
| July 30, 2026 | 3.863B |
| July 29, 2026 | 3.784B |
| July 28, 2026 | 3.816B |
| July 27, 2026 | 3.740B |
| July 24, 2026 | 3.667B |
| July 23, 2026 | 3.716B |
| July 22, 2026 | 3.751B |
| Date | Value |
|---|---|
| July 21, 2026 | 3.781B |
| July 20, 2026 | 3.633B |
| July 17, 2026 | 3.695B |
| July 16, 2026 | 3.606B |
| July 15, 2026 | 3.652B |
| July 14, 2026 | 3.594B |
| July 13, 2026 | 4.201B |
| July 10, 2026 | 4.074B |
| July 09, 2026 | 4.317B |
| July 08, 2026 | 4.235B |
| July 07, 2026 | 4.174B |
| July 06, 2026 | 4.084B |
| July 02, 2026 | 4.098B |
| July 01, 2026 | 4.122B |
| June 30, 2026 | 4.081B |
| June 29, 2026 | 4.108B |
| June 26, 2026 | 4.057B |
| June 25, 2026 | 3.924B |
| June 24, 2026 | 3.938B |
| June 23, 2026 | 3.930B |
| June 22, 2026 | 3.816B |
| June 18, 2026 | 3.698B |
| June 17, 2026 | 3.727B |
| June 16, 2026 | 3.479B |
| June 15, 2026 | 3.525B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.56B |
| Biogen, Inc. | 32.36B |
| Oncolytics Biotech, Inc. | 105.44M |
| Sangamo Therapeutics, Inc. | 61.69M |
| Sarepta Therapeutics, Inc. | 1.958B |
Market Cap Related Metrics
| PS Ratio | 1224.75 |
| PEG Ratio | -8.067 |
| Price to Book Value | 4.679 |
| Price | 24.46 |
| Earnings Yield | -11.60% |
| PEGY Ratio | -8.067 |